A detailed history of Stifel Financial Corp transactions in Novo Nordisk A S stock. As of the latest transaction made, Stifel Financial Corp holds 1,757,290 shares of NVO stock, worth $190 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
1,757,290
Previous 1,772,032 0.83%
Holding current value
$190 Million
Previous $253 Million 17.28%
% of portfolio
0.22%
Previous 0.29%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$119.07 - $145.42 $1.76 Million - $2.14 Million
-14,742 Reduced 0.83%
1,757,290 $209 Million
Q2 2024

Aug 13, 2024

BUY
$122.71 - $146.91 $9.17 Million - $11 Million
74,716 Added 4.4%
1,772,032 $253 Million
Q1 2024

May 13, 2024

BUY
$102.11 - $135.92 $7.37 Million - $9.81 Million
72,189 Added 4.44%
1,697,316 $218 Million
Q4 2023

Feb 12, 2024

BUY
$87.78 - $105.45 $8.75 Million - $10.5 Million
99,677 Added 6.53%
1,625,127 $168 Million
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $70.9 Million - $156 Million
780,110 Added 104.66%
1,525,450 $139 Million
Q2 2023

Aug 14, 2023

SELL
$155.98 - $172.65 $40.2 Million - $44.5 Million
-257,499 Reduced 25.68%
745,340 $121 Million
Q1 2023

May 12, 2023

SELL
$132.34 - $159.14 $27.3 Million - $32.9 Million
-206,573 Reduced 17.08%
1,002,839 $160 Million
Q4 2022

Feb 13, 2023

SELL
$102.55 - $135.33 $1.3 Million - $1.71 Million
-12,655 Reduced 1.04%
1,209,412 $164 Million
Q3 2022

Nov 14, 2022

SELL
$95.28 - $116.93 $1.69 Million - $2.08 Million
-17,778 Reduced 1.43%
1,222,067 $122 Million
Q2 2022

Aug 15, 2022

BUY
$103.24 - $121.81 $6.93 Million - $8.18 Million
67,162 Added 5.73%
1,239,845 $138 Million
Q1 2022

May 13, 2022

BUY
$93.1 - $112.54 $12.1 Million - $14.6 Million
129,894 Added 12.46%
1,172,683 $130 Million
Q4 2021

Feb 14, 2022

BUY
$95.88 - $117.08 $2.88 Million - $3.51 Million
30,008 Added 2.96%
1,042,789 $117 Million
Q3 2021

Nov 15, 2021

BUY
$84.42 - $106.62 $3.56 Million - $4.5 Million
42,199 Added 4.35%
1,012,781 $97.2 Million
Q2 2021

Aug 13, 2021

BUY
$67.66 - $84.76 $2.39 Million - $3 Million
35,356 Added 3.78%
970,582 $81.3 Million
Q1 2021

May 14, 2021

BUY
$67.06 - $75.82 $8.97 Million - $10.1 Million
133,799 Added 16.7%
935,226 $63.1 Million
Q4 2020

Feb 12, 2021

BUY
$63.89 - $73.8 $1.54 Million - $1.78 Million
24,125 Added 3.1%
801,427 $56 Million
Q3 2020

Nov 16, 2020

BUY
$63.69 - $70.22 $794,023 - $875,432
12,467 Added 1.63%
777,302 $54 Million
Q2 2020

Aug 14, 2020

BUY
$58.54 - $67.94 $20.6 Million - $23.9 Million
352,407 Added 85.45%
764,835 $50.1 Million
Q1 2020

May 14, 2020

BUY
$49.46 - $64.78 $4.92 Million - $6.44 Million
99,394 Added 31.75%
412,428 $24.8 Million
Q4 2019

Feb 13, 2020

BUY
$49.86 - $58.26 $1.51 Million - $1.76 Million
30,255 Added 10.7%
313,034 $18.1 Million
Q3 2019

Nov 19, 2019

SELL
$47.54 - $53.43 $8,889 - $9,991
-187 Reduced 0.07%
282,779 $14.6 Million
Q3 2019

Nov 13, 2019

BUY
$47.54 - $53.43 $1.29 Million - $1.45 Million
27,111 Added 10.6%
282,966 $14.6 Million
Q2 2019

Aug 14, 2019

SELL
$46.79 - $52.47 $106,540 - $119,474
-2,277 Reduced 0.88%
255,855 $13.1 Million
Q1 2019

May 14, 2019

BUY
$46.36 - $52.63 $778,338 - $883,605
16,789 Added 6.96%
258,132 $13.5 Million
Q4 2018

Feb 13, 2019

SELL
$41.54 - $47.25 $2.63 Million - $3 Million
-63,415 Reduced 20.81%
241,343 $11.1 Million
Q3 2018

Nov 13, 2018

SELL
$46.76 - $51.24 $1.25 Million - $1.37 Million
-26,718 Reduced 8.06%
304,758 $14.4 Million
Q2 2018

Aug 14, 2018

SELL
$44.29 - $50.42 $1.16 Million - $1.32 Million
-26,203 Reduced 7.33%
331,476 $15.3 Million
Q1 2018

May 11, 2018

SELL
$48.49 - $58.14 $286,187 - $343,142
-5,902 Reduced 1.62%
357,679 $17.6 Million
Q4 2017

Feb 14, 2018

BUY
$47.53 - $53.73 $113,263 - $128,038
2,383 Added 0.66%
363,581 $19.5 Million
Q3 2017

Nov 13, 2017

BUY
$41.15 - $49.22 $14.9 Million - $17.8 Million
361,198
361,198 $0

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $244B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.